Stockscreener 앱 받기
1.31
2.24%
-0.03
시간 외 거래:
1.33
0.02
+1.53%
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences stock hits 52-week low at $1.32 - Investing.com
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) - GuruFocus.com
2025-01-29 | Levi & Korsinsky Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:CRBU | Press Release - Stockhouse Publishing
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - GlobeNewswire
2025-01-29 | Investors who Lost Money on Caribou Biosciences, Inc. (CRBU) Should Contact Levi & Korsinsky About Pending Class ActionCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
2025-01-28 | Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit - PR Newswire
Shareholders that lost money on Caribou Biosciences, Inc. - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
FY2025 Earnings Estimate for CRBU Issued By Leerink Partnrs - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Sold by JPMorgan Chase & Co. - Defense World
TOP RANKED ROSEN LAW FIRM Encourages Caribou Biosciences, - GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Leerink Partnrs Has Negative Outlook of CRBU FY2025 Earnings - MarketBeat
Caribou Biosciences, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - Victoria Advocate
Equities Analysts Offer Predictions for CRBU FY2025 Earnings - Defense World
Caribou Biosciences stock hits 52-week low at $1.49 - MSN
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) Shareholders - PR Newswire
Caribou Biosciences stock hits 52-week low at $1.49 By Investing.com - Investing.com Canada
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to - The Bakersfield Californian
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - GlobeNewswire
Contact Levi & Korsinsky by February 24, 2025 Deadline to Join Class Action Against Caribou Biosciences, Inc. (CRBU) - GlobeNewswire
Investors who lost money on Caribou Biosciences, Inc.(CRBU) - GlobeNewswire
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for InvestorsContact Levi & Korsinsky - GuruFocus.com
Barclays PLC Has $255,000 Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
ROSEN, A LEADING NATIONAL FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionCRBU - Markets Insider
2025-01-20 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. LawsuitCRBU | NDAQ:CRBU | Press Release - Stockhouse Publishing
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou - GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Levi & Korsinsky Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineCRBU - Stockhouse Publishing
Faruqi & Faruqi Reminds Caribou Biosciences Investors of - GlobeNewswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - GlobeNewswire
CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Finansavisen
CRBU INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CRBU To Contact Him Directly To Discuss Their Options - PR Newswire
CRBU Stockholders Have Opportunity to Lead Caribou Biosciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
Investors in Caribou Biosciences, Inc. Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your RightsCRBU - Morningstar
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - Markets Insider
Caribou Biosciences, Inc. Shareholders are Encouraged to - GlobeNewswire
Caribou Biosciences, Inc. Securities Fraud Class Action - GlobeNewswire
Caribou Biosciences Advances CAR-T Therapy Trials - TipRanks
Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your RightsCRBU - PR Newswire
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 - The Manila Times
Caribou Biosciences Launches GALLOP Trial for Lupus, Reports Strong Pipeline Progress & $281M Cash Position - StockTitan
Caribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupus - TipRanks
5.49%
0.79%
자본화:
|
볼륨(24시간):